RVTY240719C110000
- 3.89
- 0.000.00%
Revvity Newsroom
Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?
Express News | Revvity Inc : Bernstein Cuts Target Price to $121 From $123
Revvity To Go Ex-Dividend On July 19th, 2024 With 0.07 USD Dividend Per Share
July 17th (Eastern Time) - $Revvity(RVTY.US)$ is trading ex-dividend on July 19th, 2024.Shareholders of record on July 19th, 2024 will receive 0.07 USD dividend per share on August 9th, 2024. The ex-
NIH Outlays Rise by 5% in June, Says Baird
Revvity To Hold Earnings Call on Monday, July 29, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced that it will release its second quarter 2024 financial results prior to market open on Monday, July 29, 2024. The Company
Leerink Partners Initiates Revvity(RVTY.US) With Buy Rating, Announces Target Price $125
Leerink Partners analyst Puneet Souda initiates coverage on $Revvity(RVTY.US)$ with a buy rating, and sets the target price at $125.According to TipRanks data, the analyst has a success rate of 32.2%
Revvity Price Target Announced at $125.00/Share by Leerink Partners
Revvity Price Target Announced at $125.00/Share by Leerink Partners
Revvity's Strategic Reshaping Poised for Market Recognition: A 'Buy' Analysis With a $125 Price Target
Express News | Revvity Inc : Leerink Partners Initiates With Outperform Rating; Price Target $125
Is Revvity, Inc.'s (NYSE:RVTY) Recent Price Movement Underpinned By Its Weak Fundamentals?
It is hard to get excited after looking at Revvity's (NYSE:RVTY) recent performance, when its stock has declined 5.7% over the past month. It seems that the market might have completely ignored the
Revvity Is Maintained at Equal-Weight by Barclays
Revvity Is Maintained at Equal-Weight by Barclays
Revvity Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/28/2024 9.82% Barclays $116 → $115 Maintains Equal-Weight 04/30/2024 21.28% Baird $126 → $127 Maintains
Express News | Revvity : Barclays Cuts Target Price to $115 From $116
Barclays Maintains Revvity(RVTY.US) With Hold Rating, Cuts Target Price to $115
Barclays analyst Luke Sergott maintains $Revvity(RVTY.US)$ with a hold rating, and adjusts the target price from $116 to $115.According to TipRanks data, the analyst has a success rate of 39.9% and a
Barclays Trims Price Target on Revvity to $115 From $116
Revvity (RVTY) has an average outperform rating and a price target range of $105 to $162, according to analysts polled by Capital IQ.
Bionano Genomics Says Revvity to Commercialize VIA Software
Bionano Genomics (BNGO) said Thursday it has signed a software marketing agreement with Revvity (RVTY) to market and commercialize VIA software. Financial details of the agreement weren't disclosed. B
Express News | Bionano Announces Software Marketing Agreement With Revvity for Newborn Sequencing Research
GenKOre Announces Strategic Collaboration With Revvity to Develop Innovative Gene Therapy Treatments
GenKOre, a pioneer in gene editing technology with its proprietary hypercompact CRISPR, known as TaRGET, is pleased to announce a strategic...
At US$107, Is It Time To Put Revvity, Inc. (NYSE:RVTY) On Your Watch List?
Today we're going to take a look at the well-established Revvity, Inc. (NYSE:RVTY). The company's stock received a lot of attention from a substantial price movement on the NYSE over the last few
Revvity(RVTY.US) Officer Sells US$441.84K in Common Stock
$Revvity(RVTY.US)$ Officer Goldberg Joel S sold 4,000 shares of common stock on Jun 7, 2024 at an average price of $110.46 for a total value of $441.84K.Source: Announcement What is statement of chang